266 related articles for article (PubMed ID: 33927319)
21. Comparison between endoscopic macroscopic classification and F-18 FDG PET findings in gastric mucosa-associated lymphoid tissue lymphoma patients.
Hirose Y; Kaida H; Ishibashi M; Uozumi J; Arikawa S; Kurata S; Hayabuchi N; Nakahara K; Ohshima K
Clin Nucl Med; 2012 Feb; 37(2):152-7. PubMed ID: 22228338
[TBL] [Abstract][Full Text] [Related]
22. 18F-Fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography in mucosa-associated lymphoid tissue lymphoma: variation in 18F-FDG avidity according to site involvement.
Park SH; Lee JJ; Kim HO; Lee DY; Suh C; Jung HY; Choi KD; Kim DH; Huh J; Ryu JS
Leuk Lymphoma; 2015; 56(12):3288-94. PubMed ID: 25804932
[TBL] [Abstract][Full Text] [Related]
23. 18F-FDG PET/CT Imaging of Primary Gastric Lymphoma.
Davis BS; Thompson TA; Wolin EA
J Nucl Med Technol; 2016 Dec; 44(4):263-264. PubMed ID: 27493260
[TBL] [Abstract][Full Text] [Related]
24. Can metabolic tumor parameters on primary staging
Okuyucu K; Alagoz E; Ince S; Ozaydin S; Arslan N
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(1):9-14. PubMed ID: 28733137
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in primary hepatic mucosa-associated lymphoid tissue lymphoma: A case report and review of the literature.
Bao C; Wei J; Zhao X; Lin L; Chen D; Liu K; Qian W; Anas JM; Zhao K
Medicine (Baltimore); 2018 Mar; 97(10):e9877. PubMed ID: 29517697
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Value of Restaging F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography to Predict 3-Year Post-Recurrence Survival in Patients with Recurrent Gastric Cancer after Curative Resection.
Kim SH; Song BI; Kim HW; Won KS; Son YG; Ryu SW
Korean J Radiol; 2020 Jul; 21(7):829-837. PubMed ID: 32524783
[TBL] [Abstract][Full Text] [Related]
27. [Value of Pretherapeutic
Ding CY; Liu HY; Guo Z; Li TN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):438-443. PubMed ID: 28446289
[TBL] [Abstract][Full Text] [Related]
28. Role of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in evaluating breast mucosa-associated lymphoid tissue lymphoma: A case series.
Albano D; Bosio G; Orlando E; Bertagna F
Hematol Oncol; 2017 Dec; 35(4):884-889. PubMed ID: 28004400
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients.
Mayerhoefer ME; Karanikas G; Kletter K; Prosch H; Kiesewetter B; Skrabs C; Porpaczy E; Weber M; Pinker-Domenig K; Berzaczy D; Hoffmann M; Sillaber C; Jaeger U; Müllauer L; Simonitsch-Klupp I; Dolak W; Gaiger A; Ubl P; Lukas J; Raderer M
Clin Cancer Res; 2014 Jun; 20(11):2984-93. PubMed ID: 24696320
[TBL] [Abstract][Full Text] [Related]
30. Pre-Therapeutic Total Lesion Glycolysis on [
Mayerhoefer ME; Staudenherz A; Kiesewetter B; Weber M; Simonitsch-Klupp I; Gibbs P; Dolak W; Lukas J; Raderer M
Mol Imaging Biol; 2019 Dec; 21(6):1192-1199. PubMed ID: 30847823
[TBL] [Abstract][Full Text] [Related]
31. Computed tomography, magnetic resonance imaging and positron emission tomography in non-Hodgkin's lymphoma.
Rodriguez M
Acta Radiol Suppl; 1998; 417():1-36. PubMed ID: 9645167
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary mucosa-associated lymphoid tissue lymphoma: computed tomography and ¹⁸F fluorodeoxyglucose-positron emission tomography/computed tomography imaging findings and follow-up.
Zhang WD; Guan YB; Li CX; Huang XB; Zhang FJ
J Comput Assist Tomogr; 2011; 35(5):608-13. PubMed ID: 21926857
[TBL] [Abstract][Full Text] [Related]
33. Clinical and pathological predictors for FDG-PET/CT avidity in patients with marginal zone lymphoma-a retrospective cohort study.
Kagan KBT; Guz D; Buchrits S; Gurion R; Vaxman I; Priss M; Groshar D; Catalano OA; Sherban A; Raanani P; Gafter-Gvili A; Bernstine H
Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2290-2299. PubMed ID: 35079846
[TBL] [Abstract][Full Text] [Related]
34. Does Delayed-Time-Point Imaging Improve 18F-FDG-PET in Patients With MALT Lymphoma?: Observations in a Series of 13 Patients.
Mayerhoefer ME; Giraudo C; Senn D; Hartenbach M; Weber M; Rausch I; Kiesewetter B; Herold CJ; Hacker M; Pones M; Simonitsch-Klupp I; Müllauer L; Dolak W; Lukas J; Raderer M
Clin Nucl Med; 2016 Feb; 41(2):101-5. PubMed ID: 26402137
[TBL] [Abstract][Full Text] [Related]
35. Metabolic tumor burden on postsurgical PET/CT predicts survival of patients with gastric cancer.
Sun G; Cheng C; Li X; Wang T; Yang J; Li D
Cancer Imaging; 2019 Mar; 19(1):18. PubMed ID: 30902116
[TBL] [Abstract][Full Text] [Related]
36. Classification of primary gastric lymphomas according to histologic features.
Hsi ED; Eisbruch A; Greenson JK; Singleton TP; Ross CW; Schnitzer B
Am J Surg Pathol; 1998 Jan; 22(1):17-27. PubMed ID: 9422312
[TBL] [Abstract][Full Text] [Related]
37. Routinely staging gastric cancer with
Findlay JM; Antonowicz S; Segaran A; El Kafsi J; Zhang A; Bradley KM; Gillies RS; Maynard ND; Middleton MR
Eur Radiol; 2019 May; 29(5):2490-2498. PubMed ID: 30643947
[TBL] [Abstract][Full Text] [Related]
38. 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma.
Hoffmann M; Kletter K; Becherer A; Jäger U; Chott A; Raderer M
Oncology; 2003; 64(4):336-40. PubMed ID: 12759529
[TBL] [Abstract][Full Text] [Related]
39. F-18 FDG PET/CT findings in a patient with bilateral orbital and gastric mucosa-associated lymphoid tissue lymphomas.
Suga K; Yasuhiko K; Hiyama A; Takeda K; Matsunaga N
Clin Nucl Med; 2009 Sep; 34(9):589-93. PubMed ID: 19692819
[TBL] [Abstract][Full Text] [Related]
40. Added value of pretreatment (18)F-FDG PET/CT for staging of advanced gastric cancer: Comparison with contrast-enhanced MDCT.
Kawanaka Y; Kitajima K; Fukushima K; Mouri M; Doi H; Oshima T; Niwa H; Kaibe N; Sasako M; Tomita T; Miwa H; Hirota S
Eur J Radiol; 2016 May; 85(5):989-95. PubMed ID: 27130061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
